| The emerging role of oncolytic virus therapy against cancer L Russell, KW Peng Chinese clinical oncology 7 (2), 16, 2018 | 147 | 2018 |
| PRMT5–PTEN molecular pathway regulates senescence and self-renewal of primary glioblastoma neurosphere cells YK Banasavadi-Siddegowda, L Russell, E Frair, VA Karkhanis, T Relation, ... Oncogene 36 (2), 263-274, 2017 | 120 | 2017 |
| Oncolytic viruses: priming time for cancer immunotherapy L Russell, KW Peng, SJ Russell, RM Diaz BioDrugs 33 (5), 485-501, 2019 | 119 | 2019 |
| The impact of macrophage-and microglia-secreted TNFα on oncolytic HSV-1 therapy in the glioblastoma tumor microenvironment WH Meisen, ES Wohleb, AC Jaime-Ramirez, C Bolyard, JY Yoo, ... Clinical Cancer Research 21 (14), 3274-3285, 2015 | 85 | 2015 |
| An oncolytic herpesvirus expressing E-cadherin improves survival in mouse models of glioblastoma B Xu, R Ma, L Russell, JY Yoo, J Han, H Cui, P Yi, J Zhang, H Nakashima, ... Nature biotechnology 37 (1), 45-54, 2019 | 75 | 2019 |
| PTEN expression by an oncolytic herpesvirus directs T-cell mediated tumor clearance L Russell, J Swanner, AC Jaime-Ramirez, Y Wang, A Sprague, ... Nature communications 9 (1), 5006, 2018 | 54 | 2018 |
| Role of cysteine-rich 61 protein (CCN1) in macrophage-mediated oncolytic herpes simplex virus clearance AH Thorne, WH Meisen, L Russell, JY Yoo, CM Bolyard, JD Lathia, J Rich, ... Molecular Therapy 22 (9), 1678-1687, 2014 | 47 | 2014 |
| Suppression of HMGB1 released in the glioblastoma tumor microenvironment reduces tumoral edema B Hong, K Muili, C Bolyard, L Russell, TJ Lee, Y Banasavadi-Siddegowda, ... Molecular Therapy-Oncolytics 12, 93-102, 2019 | 35 | 2019 |
| Stromal platelet–derived growth factor receptor-β signaling promotes breast cancer metastasis in the brain KA Thies, AM Hammer, BE Hildreth III, SA Steck, JM Spehar, RD Kladney, ... Cancer research 81 (3), 606-618, 2021 | 33 | 2021 |
| Faster replication and higher expression levels of viral glycoproteins give the vesicular stomatitis virus/measles virus hybrid VSV-FH a growth advantage over measles virus C Ayala-Breton, LOJ Russell, SJ Russell, KW Peng Journal of virology 88 (15), 8332-8339, 2014 | 32 | 2014 |
| Effects of CCN1 and macrophage content on glioma virotherapy: A mathematical model K Jacobsen, L Russell, B Kaur, A Friedman Bulletin of mathematical biology 77, 984-1012, 2015 | 18 | 2015 |
| Relationship of infusion duration to safety, efficacy, and pharmacodynamics (PD): Second part of a phase I-II study using VSV-IFNβ-NIS (VV1) oncolytic virus in patients with … JR Merchan, M Patel, TP Cripe, MO Old, JF Strauss, A Thomassen, ... Journal of Clinical Oncology 38 (15_suppl), 3090-3090, 2020 | 14 | 2020 |
| Boosting of SARS-CoV-2 immunity in nonhuman primates using an oral rhabdoviral vaccine KW Peng, T Carey, P Lech, R Vandergaast, MÁ Muñoz-Alía, ... Vaccine 40 (15), 2342-2351, 2022 | 13 | 2022 |
| Oncolytic herpes simplex virus infects myeloma cells in vitro and in vivo J Ghose, A Dona, M Murtadha, EG Gunes, E Caserta, JY Yoo, L Russell, ... Molecular Therapy-Oncolytics 20, 519-531, 2021 | 9 | 2021 |
| Exploring the possibility of using herpes simplex virus in oncolytic virotherapy of multiple myeloma J Ghose, L Russell, E Caserta, R Santhanam, AC Jaime-Ramirez, D Viola, ... Blood 128 (22), 4467, 2016 | 4 | 2016 |
| Optimization of Voyager V1 (VV1) oncolytic virus systemic delivery in combination with cemiplimab and ipilimumab in patients with melanoma and non–small cell lung cancer (NSCLC). J Lutzky, TU Marron, SF Powell, DH Johnson, M Patel, AB El-Khoueiry, ... Journal of Clinical Oncology 40 (16_suppl), TPS9595-TPS9595, 2022 | 2 | 2022 |
| An oncolytic herpes virus expressing E-cadherin resists NK cell clearance and improves viral spread and glioblastoma virotherapy B Xu, R Ma, L Russell, JY Yoo, J Han, H Cui, P Yi, J Zhang, H Nakashima, ... Nature biotechnology, 2018 | 2 | 2018 |
| Sex as a biological variable in response to temozolomide L Russell, C Bolyard, Y Banasavadi-Siddegowda, A Weiss, J Zhang, ... Neuro-oncology 19 (6), 873-874, 2017 | 2 | 2017 |
| Faster replication and higher expression of viral glycoproteins gives vsv-fh virus a growth advantage over measles virus C Ayala-Breton, LO Russell, SJ Russell, KW Peng J Virol 88, 8332-8339, 2014 | 2 | 2014 |
| The 13th International Oncolytic Virus Conference: Powerful payloads gain clinical momentum S Naik, L Russell Molecular Therapy 30 (4), 1361-1363, 2022 | 1 | 2022 |
Ji Young YooAssistant Professor, The University of Texas Health Science Center at HoustonVerified email at uth.tmc.edu
